Page 22 - Medicaid Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Thank you, everybody for coming. Continue to enjoy your lunch. Im tim carney, a visiting fellow here at American Enterprise institute as well as being the commentary editor at the Washington Examiner. We are here to talk about health care but i want to ask a a specific question about health care. Its a question that some people on the Free Enterprise side, the freemarket conservative or libertarian side dont always ask, who benefits. I think sometimes people on the right or right of center are uncomfortable with that question in policy debates because they say why should it matter who benefits...

The presiding officer the senator from louisiana. Kennedys mr. Kennedy thank you, madam president. I want to talk for a few moments this morning about money, 5g and radio waves. Mr. Kennedy a radio wave is nothing more than electromagnetic radiation moving through the air. Thats all a radio wave is. Think of it as a imagine a pond, and think of a radio wave as a ripple or wave in that pond. The wave goes like this and has a peak and a valley and peak and a valley, and eventually it gets shorter and shorter. Thats what a radio wave is. And there are different kind of radio waves. I dont know ho...

Host this week on newsmakers, former republican congressman James Greenwood from pennsylvania, served from 1993 to and currently is president 2005 and ceo of the Biotechnology Innovation Organization. We also have Peter Sullivan, reporter with the hill. And sarah carlon smith. Welcome to you all. Congressman, what is your organization, the Biotechnology Innovation Organization . James we are the National Trade association for about 1000 biotechnology companies. Most of them in the Drug Discovery business. When you think of pharma, they have the Biggest Companies in the industry merck, pfizer, ...

Participants raised their hands and said yes. Thats an arguable position. There are arguments for and against that. But the first question you need to answer in this as in any other policy proposal is what is this going to cost. And there simply hasnt been very much interest or exploration in this question x. So thats why were releasing the two papers were releasing today and having this panel discussion, is precisely to get a sense of what it could cost us. Not definitive, these are estimates. Maybe theyll be different. Other people have other estimates. Wed love to see them, but nobody reall...

Peter sullivan is a reporter withthe hell, and the hill. What is the Biotechnology Innovation Organization . Trade we are the national a Photo Association for about 1000 biotech companies, most in the Drug Discovery business. When you think of pharma with a capital p, they are the biggest companies, mercks, pfizer merck, pfizer, Johnson Johnson. What distinguishes us is we have hundreds of Startup Companies that are on the cutting edge of biotechnology innovation of new medicines. drug pricing is the hot issue. Thatve seen polling data about three in 10 americans are basically rationing medici...